Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02272855
Title A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Takara Bio Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Clinical Site San Francisco California 94115 United States Details
Clinical Site Atlanta Georgia 30322 United States Details
Clinical Site Portland Oregon 97239 United States Details
Clinical Site Bethlehem Pennsylvania 18015 United States Details
Clinical Site Hershey Pennsylvania 17033 United States Details
Clinical Site Dallas Texas 75230 United States Details
Clinical Site Houston Texas 77030 United States Details
Clinical Site Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field